mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.0002 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |